Small Cap Healthcare Stock on A Tear as two leading candidates are tested against SARS-CoV-2

A small cap healthcare company, whose stock has zoomed up 7x since the March lows, has embarked upon the race to undertake initial study of its drug candidates RECCE® 327 and RECCE® 529. The company’s two leading candidates are being te...
After weeks of lockdowns in most affected countries, the seriousness of socio-economic

Fill in the details below to get full access of the article.

By submitting your details, you agree to receive the marketing offers and to be contacted by email or phone as per our Privacy Policy.

   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK